Bruno Pougault/LinkedIn
Sep 27, 2025, 05:30
Bruno Pougault: New Medical Scientific Publication Once Again Demonstrating the Importance of D Dimer
Bruno Pougault, Global Marketing Hemostasis Product Manager at HORIBA, shared on LinkedIn:
”New medical scientific publication once again demonstrating the importance of D Dimer.
D-dimer as a predictive biomarker for cancer-associated thrombosis: A prospective cohort study
Elsaca, E. et al.
Thrombosis Research, Volume 254, 109448”
Read the full article in Thrombosis Research.
Article: D-dimer as a predictive biomarker for cancer-associated thrombosis: A prospective cohort study
Authors: E. Elsaca, J. López, A. Valenzuela, A. González, J. Cerda, B. Nervi, A. Aizman

Stay updated on all scientific advances in the field of thrombosis with Hemostasis Today.
-
Jan 12, 2026, 14:46A Behcet Disease with Aortic Thrombosis: Alexandru Stieber Shares A Peculiar Case
-
Jan 12, 2026, 04:51Coronary Microvascular Dysfunction and HFpEF․ Prognostic Importance and Therapeutic Insights
-
Jan 12, 2026, 04:16Wolfgang Miesbach on VTE and Cancer: A 20-Year Signal That Can’t Be Ignored
-
Jan 12, 2026, 03:54Francine Freitas Fernandes on Transvaginal US for Pelvic Venous Disorders
-
Jan 12, 2026, 02:58Jara Garcia Ugaldebere Shares STORM-PE Results: Thrombectomy Plus Anticoagulation for Acute High-Risk PE
-
Jan 12, 2026, 02:54Discover the New Blood Project․ Enhanced Search, Browsing, and Learning Resources
-
Jan 12, 2026, 02:54Can Preoperative Iron Status Predict Severe Anemia After Bariatric Surgery?
-
Jan 12, 2026, 02:27Bryce Kerlin to Impact of Advanced Hemostasis/Thrombosis Fellowship Training at Haemophilia Publication
-
Jan 12, 2026, 02:21Martin Haluzík on Compariosn of Cardiovascular Outcomes Between Semaglutide and Dulaglutide Therapies
